Furthermore, induction of PGC-1α in cells via catecholamine treatment can reverse the mitochondrial genes inhibition, suggesting that PGC-1α may be a potential therapeutic target in heart failure [68]. The gene discussed is PPARGC1A; the disease is heart failure.